Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem Limited submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 31 March 2026. The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's Registrar and Share Transfer Agent. It confirms that all securities received for dematerialisation during the quarter were processed and accepted/rejected, and that dematerialised securities have been listed on the relevant stock exchanges. The RTA also confirmed that physical share certificates received were mutilated and cancelled after verification, with depository names updated as registered owners in the register of members within prescribed timelines. The filing was made on 6 April 2026 for scrip code 543321.
This is a routine regulatory compliance filing and does not directly impact the company's financial position or shareholder value. It confirms proper processing of dematerialisation requests during the quarter.